New non-surgical treatments like this one need to be properly assessed and scrutinised by scientific publications. Dr Vahe disagrees
They will look at your blood markers alongside your clinical history to make a safe and informed decision
For those interested in exploring telehealth access, patients can view the current compounded GLP-1 offer (official MEDVi page) and speak with a licensed clinician about whether evaluation may be appropriate for their specific circumstances
So then talk us through how did they get into more of the mainstream
Gutzwiller JP, Tschopp S, Bock A, Zehnder CE, Huber AR, Kreyenbuehl M et al (2004) Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions